Apple and Samsung reportedly resume patent talks

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Apple and Samsung reportedly resume patent talks

Apple and Samsung have reportedly resumed talks in an effort to settle their differences over patent infringement claims relating to smartphone technology.

The Korea Times reports that the rival companies are trying to work out a deal over royalty payments, while the Korean Fair Trade Commission has teamed up with anti-trust officials in Europe and the US to discuss the situation.

The news is the latest installment in a long-running series of disputes between the two companies over Smartphone technology.

In November, a jury in California revised damages Samsung was required to pay to Apple to just over $900 million. The verdict was the result of a retrial of a jury verdict in August last year, which concluded that Samsung had infringed five utility and design patents relating to the iPhone 5 and awarded Apple $1 billion in damages.

But the Federal Circuit resurrected the chance for Apple to secure a permanent ban on US sales of the infringing products when it unanimously ruled that District Judge Lucy Koh, who presided over the case, erred in denying Apple’s motion for a permanent injunction.

Last week, Apple filed another motion with the same court to block Samsung from selling the products in the US.

In the motion, Apple argues that an injunction would not be against the public interest because Samsung has already stopped selling the products in question, but that without an injunction Samsung could sell other infringing products in future.

Apple has requested a hearing on the motion before January 30.

more from across site and SHARED ros bottom lb

More from across our site

Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Practitioners have welcomed extended funding of the specialist police unit until 2029, while the UKIPO says it is exploring increased scale
Abion says integration with Baylos marks an important step in the company’s international expansion plans
Via Licensing Alliance continues its China push as another smartphone manufacturer joins patent pool as licensee
Law firm mergers have the potential to reshape IP teams, and partners who were at the coalface of previous tie-ups say early coordination and flexibility can make the difference
Women are entering the IP profession, but still too few are being trusted with the clients, cases, and credit that may open the path to leadership
In other news, Australia’s IP office has announced expanded search options, and an EPO report shed light on slow progress relating to women inventors in Europe
Managing IP speaks with up-and-coming women lawyers at five law firms about fighting imposter syndrome, maintaining work-life balance and why real representation matters
Gift this article